Skip to main content
Top
Published in: BMC Nephrology 1/2023

Open Access 01-12-2023 | Fluconazole | Case report

Peritoneal dialysis related eosinophilic peritonitis: a case report and review of the literature

Authors: Zhang Qingyan, Xia Yangyang, Zhang Miao, Jiang Chunming

Published in: BMC Nephrology | Issue 1/2023

Login to get access

Abstract

Background

Overt eosinophilic peritonitis (EP) is a relatively uncommon complication of peritoneal dialysis (PD), although not rare. Here we reported a case of EP relieved after changing dialysate. 

Case presentation

A 28-year old male patient developed cloudy PD effluents within the first month after PD started. Cytological study of PD effluents showed elevated white blood cells and polynuclear cells. Bacteria culture of PD effluents repeated for several times were all negative, and no pathogen was found by metagenomics next generation sequencing (mNGS). Antibiotic therapy for 28-day was ineffective. Based on these and increased eosinophils in peritoneal fluid, he was finally diagnosed as EP. PD dialysate was changed (consists of the same buffer agent and electrolytes, but is packed in bags that do not contain PVC), and the patient’s PD effluent became clear. Of note, EP did not relapse 5 months later when the patient started to use the former PD solution again.

Conclusion

Although PD effluent turbidity almost always represents infectious peritonitis, there are other differential diagnoses including EP. For patients with cloudy fluid accompanied by mild symptoms who do not response to antibiotic therapy, it is reasonable to consider the possibility of this disease. EP tends to heal spontaneously, however, antihistamines or glucocorticoids are required sometimes to avoid catheter obstruction. For patients with no obvious incentives, replacement of dialysate may be useful.
Literature
1.
go back to reference Lee S, Schoen I. Eosinophilia of peritoneal fluid and peripheral blood associated with chronic peritoneal dialysis. Am J Clin Pathol. 1967;47(5):638–40.CrossRef Lee S, Schoen I. Eosinophilia of peritoneal fluid and peripheral blood associated with chronic peritoneal dialysis. Am J Clin Pathol. 1967;47(5):638–40.CrossRef
2.
go back to reference Chan MK, Chow L, Lam SS, Jones B. Peritoneal eosinophilia in patients on continuous ambulatory peritoneal dialysis: a prospective study. Am J Kidney Dis. 1988;11(2):180–3.CrossRef Chan MK, Chow L, Lam SS, Jones B. Peritoneal eosinophilia in patients on continuous ambulatory peritoneal dialysis: a prospective study. Am J Kidney Dis. 1988;11(2):180–3.CrossRef
3.
go back to reference Fontan MP, Rodriguez-Carmona A, Galed I, Iglesias P, Villaverde P, Garcia-Ureta E. Incidence and significance of peritoneal eosinophilia during peritoneal dialysis-related peritonitis. Perit Dial Int. 2003;23(5):460–4.CrossRef Fontan MP, Rodriguez-Carmona A, Galed I, Iglesias P, Villaverde P, Garcia-Ureta E. Incidence and significance of peritoneal eosinophilia during peritoneal dialysis-related peritonitis. Perit Dial Int. 2003;23(5):460–4.CrossRef
4.
go back to reference Jo YI, Song JO, Park JH, Lee JH, Shin SK. Idiopathic eosinophilic peritonitis in continuous ambulatory peritoneal dialysis: experience with percutaneous catheter placement. Nephrol (Carlton). 2007;12(5):437–40.CrossRef Jo YI, Song JO, Park JH, Lee JH, Shin SK. Idiopathic eosinophilic peritonitis in continuous ambulatory peritoneal dialysis: experience with percutaneous catheter placement. Nephrol (Carlton). 2007;12(5):437–40.CrossRef
5.
go back to reference Piraino BM, Silver MR, Dominguez JH, Puschett JB. Peritoneal eosinophils during intermittent peritoneal dialysis. Am J Nephrol. 1984;4(3):152–7.CrossRef Piraino BM, Silver MR, Dominguez JH, Puschett JB. Peritoneal eosinophils during intermittent peritoneal dialysis. Am J Nephrol. 1984;4(3):152–7.CrossRef
6.
go back to reference Ejaz AA, Fitzpatrick PM, Durkin AJ, Wasiluk A, Haley WE, Goalen MJ, et al. Pathophysiology of peritoneal fluid eosinophilia in peritoneal dialysis patients. Nephron. 1999;81(2):125–30.CrossRef Ejaz AA, Fitzpatrick PM, Durkin AJ, Wasiluk A, Haley WE, Goalen MJ, et al. Pathophysiology of peritoneal fluid eosinophilia in peritoneal dialysis patients. Nephron. 1999;81(2):125–30.CrossRef
7.
go back to reference Xu Y, Gao C, Xu J, Chen N. Successful treatment of idiopathic eosinophilic peritonitis by oral corticosteroid therapy in a continuous ambulatory peritoneal Dialysis patient. Case Rep Nephrol Dial. 2015;5(2):130–4.CrossRef Xu Y, Gao C, Xu J, Chen N. Successful treatment of idiopathic eosinophilic peritonitis by oral corticosteroid therapy in a continuous ambulatory peritoneal Dialysis patient. Case Rep Nephrol Dial. 2015;5(2):130–4.CrossRef
8.
go back to reference Oh SY, Kim H, Kang JM, Lim SH, Park HD, Jung SS, et al. Eosinophilic peritonitis in a patient with continuous ambulatory peritoneal dialysis (CAPD). Korean J Intern Med. 2004;19(2):121–3.CrossRef Oh SY, Kim H, Kang JM, Lim SH, Park HD, Jung SS, et al. Eosinophilic peritonitis in a patient with continuous ambulatory peritoneal dialysis (CAPD). Korean J Intern Med. 2004;19(2):121–3.CrossRef
9.
go back to reference Rosner MH, Chhatkuli B. Vancomycin-related eosinophilic peritonitis. Perit Dial Int. 2010;30(6):650–2.CrossRef Rosner MH, Chhatkuli B. Vancomycin-related eosinophilic peritonitis. Perit Dial Int. 2010;30(6):650–2.CrossRef
10.
go back to reference Daugirdas JT, Leehey DJ, Popli S, Hoffman W, Zayas I, Gandhi VC, et al. Induction of peritoneal fluid eosinophilia and/or monocytosis by intraperitoneal air injection. Am J Nephrol. 1987;7(2):116–20.CrossRef Daugirdas JT, Leehey DJ, Popli S, Hoffman W, Zayas I, Gandhi VC, et al. Induction of peritoneal fluid eosinophilia and/or monocytosis by intraperitoneal air injection. Am J Nephrol. 1987;7(2):116–20.CrossRef
11.
go back to reference Fourtounas C, Dousdampanis P, Hardalias A, Liatsikos E, Vlachojannis JG. Eosinophilic peritonitis following air entrapment during peritoneoscopic insertion of peritoneal dialysis catheters. Semin Dial. 2008;21(2):180–2.CrossRef Fourtounas C, Dousdampanis P, Hardalias A, Liatsikos E, Vlachojannis JG. Eosinophilic peritonitis following air entrapment during peritoneoscopic insertion of peritoneal dialysis catheters. Semin Dial. 2008;21(2):180–2.CrossRef
12.
go back to reference Hsu CY, Lee DJ, Lin SH. Severe eosinophilic peritonitis caused by intraperitoneal vancomycin administration. Clin Nephrol. 2021;96(3):184–7.CrossRef Hsu CY, Lee DJ, Lin SH. Severe eosinophilic peritonitis caused by intraperitoneal vancomycin administration. Clin Nephrol. 2021;96(3):184–7.CrossRef
13.
go back to reference Wong PN, Mak SK, Lee KF, Fung LH, Wong AK. A prospective study of vancomycin-(Vancoled-)induced chemical peritonitis in CAPD patients. Perit Dial Int. 1997;17(2):202–4.CrossRef Wong PN, Mak SK, Lee KF, Fung LH, Wong AK. A prospective study of vancomycin-(Vancoled-)induced chemical peritonitis in CAPD patients. Perit Dial Int. 1997;17(2):202–4.CrossRef
14.
go back to reference Rathi M. Intraperitoneal streptokinase use-associated eosinophilic peritonitis. Saudi J Kidney Dis Transpl. 2015;26(1):128–31.CrossRef Rathi M. Intraperitoneal streptokinase use-associated eosinophilic peritonitis. Saudi J Kidney Dis Transpl. 2015;26(1):128–31.CrossRef
15.
go back to reference Minato S, Miyazawa H, Kitano T, Shindo M, Ito K, Ueda Y, et al. Eosinophilic peritonitis induced by sucroferric oxyhydroxide. Perit Dial Int. 2020;40(4):419–21.CrossRef Minato S, Miyazawa H, Kitano T, Shindo M, Ito K, Ueda Y, et al. Eosinophilic peritonitis induced by sucroferric oxyhydroxide. Perit Dial Int. 2020;40(4):419–21.CrossRef
16.
go back to reference Solary E, Cabanne JF, Tanter Y, Rifle G. Evidence for a role of plasticizers in ‘eosinophilic’ peritonitis in continuous ambulatory peritoneal dialysis. Nephron. 1986;42(4):341–2.CrossRef Solary E, Cabanne JF, Tanter Y, Rifle G. Evidence for a role of plasticizers in ‘eosinophilic’ peritonitis in continuous ambulatory peritoneal dialysis. Nephron. 1986;42(4):341–2.CrossRef
17.
go back to reference Chan Z, Hui YH, Wong SSH. Resolution of severe eosinophilic peritonitis in a patient on continuous ambulatory peritoneal dialysis by changing from Dianeal peritoneal dialysis solution to stay-safe balance solution: a case report. BMC Nephrol. 2022;23(1):149.CrossRef Chan Z, Hui YH, Wong SSH. Resolution of severe eosinophilic peritonitis in a patient on continuous ambulatory peritoneal dialysis by changing from Dianeal peritoneal dialysis solution to stay-safe balance solution: a case report. BMC Nephrol. 2022;23(1):149.CrossRef
18.
go back to reference Bommer J, Ritz E, Andrassy K. Necrotizing dermatitis resulting from hemodialysis with polyvinylchloride tubing. Ann Intern Med. 1979;91(6):869–70.CrossRef Bommer J, Ritz E, Andrassy K. Necrotizing dermatitis resulting from hemodialysis with polyvinylchloride tubing. Ann Intern Med. 1979;91(6):869–70.CrossRef
19.
go back to reference Rocklin MA, Teitelbaum I. Noninfectious causes of cloudy peritoneal dialysate. Semin Dial. 2001;14(1):37–40.CrossRef Rocklin MA, Teitelbaum I. Noninfectious causes of cloudy peritoneal dialysate. Semin Dial. 2001;14(1):37–40.CrossRef
20.
go back to reference Keane WF, Bailie GR, Boeschoten E, Gokal R, Golper TA, Holmes CJ, et al. Adult peritoneal dialysis-related peritonitis treatment recommendations: 2000 update. Perit Dial Int. 2000;20(4):396–411.CrossRef Keane WF, Bailie GR, Boeschoten E, Gokal R, Golper TA, Holmes CJ, et al. Adult peritoneal dialysis-related peritonitis treatment recommendations: 2000 update. Perit Dial Int. 2000;20(4):396–411.CrossRef
Metadata
Title
Peritoneal dialysis related eosinophilic peritonitis: a case report and review of the literature
Authors
Zhang Qingyan
Xia Yangyang
Zhang Miao
Jiang Chunming
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2023
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-022-03027-8

Other articles of this Issue 1/2023

BMC Nephrology 1/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine